Doctoral Research Fellow

Martinecz, Antal

Computational Pharmacology, Research Group
Flag icon Flag icon

Mathematical modeling, Pharmacodynamics, Antibiotics, Tubercolosis

  • Clarelli, Fabrizio; Liang, Jingyi; Martinecz, Antal; Heiland, Ines; Abel zur Wiesch, Pia. Multi-scale modeling of drug binding kinetics to predict drug efficacy. Cellular and Molecular Life Sciences (CMLS) 2019. ISSN 1420-682X.s doi: 10.1007/s00018-019-03376-y.

  • Martinecz, Antal; Clarelli, Fabrizio; Abel, Sören; Abel zur Wiesch, Pia. Reaction Kinetic Models of Antibiotic Heteroresistance. International Journal of Molecular Sciences 2019; Volum 20 (16). ISSN 1422-0067.s doi: 10.3390/ijms20163965.

  • Martinecz, Antal; Abel zur Wiesch, Pia. Estimating treatment prolongation for persistent infections. Pathogens and Disease 2018; Volum 76 (6). ISSN 2049-632X.s doi: 10.1093/femspd/fty065.

  • Martinecz, Antal; Niitsuma, Mihoko. Fractional integral-like processing in retinal cones reduces noise and improves adaptation. PLOS ONE 2018; Volum 13 (10). ISSN 1932-6203.s doi: 10.1371/journal.pone.0205099.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Conference presentation at "2nd Arctic Meeting on Clinical Tuberculosis". 2nd Arctic Meeting on Clinical Tuberculosis 2019-02-22 - 2019.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak rifampicin plasma concentrations accelerate the slow phase of bacterial elimination in tuberculosis patients. Norwegian PhD School of Pharmacy Annual Meeting 2019 2019-05-27 - 2019-05-28 2019.

  • Abel zur Wiesch, Pia; Robson Moe, Natasha-Anne; Lauksund, Silje; Martinecz, Antal. Bacterial replication and death rates during exposure to bactericidal antibiotics. 2019.

  • Martinecz, Antal; Abel zur Wiesch, Pia; Regoes, Roland R.. Within Host Infection Dynamics: Persisters can infect new sites and cause relapse if the immune clearance is low. Conference "Challenges and new concepts in antibiotics research”, Institute Pasteur, Paris, France 2018-03-19 - 2018-03-21 2018.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Conference presentation at "International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018" The Hague, Netherlands. International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018 2018-10-23 - 2018.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Autumn meeting, National Graduate School in Infection Biology and Antimicrobials 2018-10-29 - 2018-10-30 2018.

  • Martinecz, Antal; Abel zur Wiesch, Pia; Regoes, Roland. Persistence lengthens the treatment of chronic infections. NORBIS PhD school annual meeting 2018-10-17 - 2018-10-18 2018.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Conference presentation at "2nd Arctic Meeting on Clinical Tuberculosis". 2nd Arctic Meeting on Clinical Tuberculosis 2019-02-22 - 2019.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak rifampicin plasma concentrations accelerate the slow phase of bacterial elimination in tuberculosis patients. Norwegian PhD School of Pharmacy Annual Meeting 2019 2019-05-27 - 2019-05-28 2019.

  • Abel zur Wiesch, Pia; Robson Moe, Natasha-Anne; Lauksund, Silje; Martinecz, Antal. Bacterial replication and death rates during exposure to bactericidal antibiotics. 2019.

  • Martinecz, Antal; Abel zur Wiesch, Pia; Regoes, Roland R.. Within Host Infection Dynamics: Persisters can infect new sites and cause relapse if the immune clearance is low. Conference "Challenges and new concepts in antibiotics research”, Institute Pasteur, Paris, France 2018-03-19 - 2018-03-21 2018.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Conference presentation at "International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018" The Hague, Netherlands. International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018 2018-10-23 - 2018.

  • Martinecz, Antal; Boeree, Martin J.; Diacon, Andreas H.; Dawson, Rodney; Aarnoutse, Rob E.; Abel zur Wiesch, Pia. High peak drug concentrations increase the bactericidal action in the slow phase of bacterial elimination in EBA trials of tuberculosis patients. Autumn meeting, National Graduate School in Infection Biology and Antimicrobials 2018-10-29 - 2018-10-30 2018.

  • Martinecz, Antal; Abel zur Wiesch, Pia; Regoes, Roland. Persistence lengthens the treatment of chronic infections. NORBIS PhD school annual meeting 2018-10-17 - 2018-10-18 2018.

  • Member of research group

    [Loading...]